Cortice Biosciences, Inc. - 29 Jul 2024 Form 3 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
10%+ Owner
Signature
Cortice Biosciences, Inc., /s/ Michael Weiser, Director
Issuer symbol
CNSP
Transactions as of
29 Jul 2024
Net transactions value
$0
Form type
3
Filing time
06 Aug 2024, 16:53:41 UTC
Next filing
06 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNSP Common Stock 573,368 29 Jul 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.